Skip to main content

Policies & Code of Conduct

Spark maintains a formal set of compliance policies that govern how Spark, its employees, and its business partners — including downline agencies, agents, and vendors — operate. Below is a summary of three key policies, with links to the full documents.

Business Partner Code of Conduct

Version 2.0 · Effective June 30, 2026

This Code applies to all Business Partners of Spark Health Inc. and its subsidiaries — including downline agencies, agents, contractors, affiliates, consultants, suppliers, vendors, and distributors. It sets expectations for lawful and ethical conduct in any interaction with Spark, covering:

  • Compliance with CMS, HIPAA, FWA, anti-kickback, data privacy, and labor laws

  • Honest and fair dealings, including prohibitions on false or misleading statements and financial documentation

  • Anti-harassment and non-discrimination

  • Conflicts of interest and gift/hospitality limits

  • Reporting misconduct and protection from retaliation

  • Alcohol and drug use standards

Suspected violations, conflicts of interest, or questions can be reported to [email protected].

Compliance Program Policy

Control #: CMP-POL-001-P · Version 1.1 · Effective July 21, 2025

This policy establishes Spark's overall Compliance Program, built on the seven elements of an effective compliance program as defined by the HHS Office of Inspector General. It applies to all Spark employees, contractors, business partners, and third parties performing work on Spark's behalf, and covers:

  • The regulatory framework Spark operates under, including CMS requirements (42 CFR §§422.503, 423.504), HIPAA, and SOC 2

  • Compliance leadership and oversight, led by Spark's Compliance Officer and a Compliance Committee

  • Required annual training for all Associates and FDRs, including General Compliance, HIPAA, Conflict of Interest, and Fraud, Waste, and Abuse (FWA) Prevention

  • Multiple confidential and anonymous reporting channels, with a zero-tolerance stance on retaliation

  • Ongoing monitoring, auditing, and risk assessment, including oversight of the Compliance Agency Monitoring Program (CAMP)

  • Enforcement of standards and response to detected violations

This policy is reviewed at least annually. Individuals may report compliance concerns anonymously without fear of retaliation.

Third-Party Marketing Organization (TPMO) Oversight Policy

Control #: CMP-POL-015-P · Version 2.0 · Effective July 17, 2026

This policy sets the rules for how Medicare Advantage, Part D, Medicare Supplement, and ancillary health products are sold and marketed by Spark and its downline agencies, agents, and lead vendors. It's grounded in CMS's Medicare Communications and Marketing Guidelines (MCMG), the CMS TPMO Final Rule, and 42 CFR §§422 and 423. Key areas covered include:

  • Scope of Appointment (SOA), needs assessments, and enrollment process requirements

  • Call recording, the TPMO disclaimer, and rules against unsolicited contact

  • Open Enrollment Period (OEP) marketing restrictions and anti-discrimination requirements

  • Limits on gifts and meals at marketing and sales events

  • Content requirements for marketing and communication materials, including required carrier/CMS submission

  • Lead vendor contracting, disclosure, and consent requirements

  • Monitoring and enforcement through Spark's Compliance Agency Monitoring Program (CAMP)

Important: Downline agencies may not circumvent this policy by operating through affiliated entities, subcontractors, alternative TPMO structures, or undisclosed marketing arrangements.

Questions about this policy can be directed to [email protected].


Did this answer your question?